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Background/Introduction
Benefit from resection of the primary tumour in stage IV
renal and breast cancer has been demonstrated. This has
never been shown in patients with stage IV lung cancer.
Aims/Objectives
To establish the feasibility of a trial in NSCLC we
assessed the proportion of stage IV patients in whom
video-assisted thoracoscopic (VAT) wedge resection of
the primary lesion would be possible.
Method
A prospective lung cancer database was analysed to
identify patients with stage IV lung cancer. Inclusion
criteria included: WHO performance status of 0-2 and
histologically confirmed NSCLC. Patients with cerebral
metastases were excluded. The images of these patients
were independently reviewed by two surgeons to deter-
mine the suitability for a VATS wedge resection of the
primary lesion. Areas of discrepancy were resolved by a
third senior reviewer.
Results
Over a 14-month period, 893 patients with stage IV lung
cancer were identified. A sample of 300 consecutive
patients (34%) with a performance status of 0-2 were ana-
lysed of which 30 were excluded as they did not fulfil the
primary criteria. Thirty-six (16%) of the remaining 230
had histological confirmation and no cerebral metastases.
A further 23 patients were excluded due to the size or
location of the primary. Thirteen patients (5.6%): median
age 70 years (IQR: 64-76 years) were found to be suitable
for a VATS wedge resection and the most common cell
type was adenocarcinoma (46%).
Discussion/Conclusion
A proposed trial of resecting the primary in stage IV
NSCLC would be challenging as a busy unit would only
have one candidate per month. This data will guide the
design of a future multicentre trial.
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